Christina Sutherland

Author

Hartford Hospital

Also Known As

Christina A Sutherland, Christina A. Sutherland, Christina Sutherland

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Hartford Hospital Hartford Financial Services (United States)Aichi Medical University

About

Christina Sutherland is an author at Hartford Hospital specializing in medicine, pharmacology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	535
2	Health Sciences	8	8	220
3	Allergy	1	1	51
4	Biochemistry	1	1	30
5	Diabetes	1	1	49

Christina Sutherland

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Comparison of 2 Blood Culture Media Shows Significant Differences in Bacterial Recovery for Patients on Antimicrobial Therapy Rebecca Zadroga, David N. Williams, Richard L. Gottschall, Clinical Infectious Diseases	2012	114
Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds Mordechai Grupper, Christina Sutherland, David P. Nicolau Antimicrobial Agents and Chemotherapy	2017	83
Optimal Dosing of Piperacillin‐Tazobactam for the Treatment of <i>Pseudomonas aeruginosa</i> Infections: Prolonged or Continuous Infusion? Aryun Kim, Christina Sutherland, Joseph L. Kuti, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2007	76
In Vivo Microdialysis Study of the Penetration of Daptomycin into Soft Tissues in Diabetic versus Healthy Volunteers Aryun Kim, Larry A. Suecof, Christina Sutherland, Antimicrobial Agents and Chemotherapy	2008	69
Pharmacokinetics of Meropenem 0.5 and 2 g Every 8 Hours as a 3‐Hour Infusion Prachi K. Dandekar, Dana Maglio, Christina Sutherland, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2003	64
Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals Christina Sutherland, David P. Nicolau Clinical Therapeutics Antimicrobial SusceptibilityAntibioticsKlebsiella PneumoniaeSusceptibility ProfileAntibacterial Agent	2015	58
Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against <i>Klebsiella pneumoniae</i> Producing the KPC Carbapenemase versus That against <i>Pseudomonas aeruginosa</i> in an <i>In Vitro</i> Pharmacodynamic Model Catharine C. Bulik, Henry Christensen, Peng Li, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeAntimicrobial ChemotherapyKpc IsolatesBacterial PathogensPharmacodynamic Modeling	2009	56
<i>In Vivo</i> Comparison of CXA-101 (FR264205) with and without Tazobactam versus Piperacillin-Tazobactam Using Human Simulated Exposures against Phenotypically Diverse Gram-Negative Organisms Catharine C. Bulik, Pamela R. Tessier, Rebecca A. Keel, Antimicrobial Agents and Chemotherapy	2011	55
Development of HPLC Methods for the Determination of Vancomycin in Human Plasma, Mouse Serum and Bronchoalveolar Lavage Fluid Mao Hagihara, Christina Sutherland, David P. Nicolau Journal of Chromatographic Science ImmunologyPlasma MedicineGas ChromatographyBioanalysisAnalytical Chemistry	2012	51
Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using <i>In Vivo</i> Microdialysis Catharine C. Bulik, Dora E. Wiskirchen, Ashley Shepard, Antimicrobial Agents and Chemotherapy Therapeutic Drug MonitoringAntibioticsMedicineTissue PenetrationDiabetes	2010	49

Page 1